BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16117710)

  • 1. Vaccines for lyssaviruses other than rabies.
    Nel LH
    Expert Rev Vaccines; 2005 Aug; 4(4):533-40. PubMed ID: 16117710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.
    Evans JS; Selden D; Wu G; Wright E; Horton DL; Fooks AR; Banyard AC
    J Gen Virol; 2018 Feb; 99(2):169-180. PubMed ID: 29300155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
    Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of lyssaviruses in Eurasia.
    McElhinney LM; Marston DA; Stankov S; Tu C; Black C; Johnson N; Jiang Y; Tordo N; Müller T; Fooks AR
    Dev Biol (Basel); 2008; 131():125-31. PubMed ID: 18634471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2.
    Müller T; Selhorst T; Burow J; Schameitat A; Vos A
    Dev Biol (Basel); 2006; 125():195-204. PubMed ID: 16878477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Discussion on the article Ondrejková A et al.: Transmission of lyssavirus infections from bats to man. Klin mikrobiol inf lek 2003;9:280-3].
    Benes J; Korínková M
    Klin Mikrobiol Infekc Lek; 2004 Feb; 10(1):34. PubMed ID: 15100983
    [No Abstract]   [Full Text] [Related]  

  • 7. Human rabies due to lyssavirus infection of bat origin.
    Johnson N; Vos A; Freuling C; Tordo N; Fooks AR; Müller T
    Vet Microbiol; 2010 May; 142(3-4):151-9. PubMed ID: 20188498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?
    Evans JS; Horton DL; Easton AJ; Fooks AR; Banyard AC
    Vaccine; 2012 Dec; 30(52):7447-54. PubMed ID: 23084854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon in lyssavirus infection.
    Rieder M; Finke S; Conzelmann KK
    Berl Munch Tierarztl Wochenschr; 2012; 125(5-6):209-18. PubMed ID: 22712418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple sandwich ELISA (WELYSSA) for the detection of lyssavirus nucleocapsid in rabies suspected specimens using mouse monoclonal antibodies.
    Xu G; Weber P; Hu Q; Xue H; Audry L; Li C; Wu J; Bourhy H
    Biologicals; 2007 Oct; 35(4):297-302. PubMed ID: 17276082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses.
    Weir DL; Coggins SA; Vu BK; Coertse J; Yan L; Smith IL; Laing ED; Markotter W; Broder CC; Schaefer BC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
    Perrin P; Jacob Y; Desmézières E; Tordo N
    Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe.
    Servat A; Wasniewski M; Cliquet F
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31614675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabies: epidemiological tendencies and control tools.
    Tordo N; Bahloul C; Jacob Y; Jallet C; Perrin P; Badrane H
    Dev Biol (Basel); 2006; 125():3-13. PubMed ID: 16878455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabies and other lyssavirus diseases.
    Warrell MJ; Warrell DA
    Lancet; 2004 Mar; 363(9413):959-69. PubMed ID: 15043965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyssaviruses: special emphasis on rabies virus and other members of the lyssavirus genus.
    Harkess G; Fooks AR
    Methods Mol Biol; 2011; 665():279-307. PubMed ID: 21116807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic diversity of Lyssavirus].
    Bahloul C; Badrane H; Sacramento D; Fayaz A; Loza-Rubio E; Aguilar-Sétien A; Bachir K; Bourhy H; Tordo N
    Bull Soc Pathol Exot; 2000 Jul; 93(3):181. PubMed ID: 11030054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-based immunization against Lyssaviruses.
    Perrin P; Jacob Y; Tordo N
    Intervirology; 2000; 43(4-6):302-11. PubMed ID: 11251386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of new and emerging lyssaviruses.
    Fooks A
    Expert Rev Vaccines; 2004 Aug; 3(4):333-6. PubMed ID: 15270628
    [No Abstract]   [Full Text] [Related]  

  • 20. Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe.
    Echevarría JE; Banyard AC; McElhinney LM; Fooks AR
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31554170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.